Pošalji zapis e-poštom: IMMU-14. IMPLICATIONS FOR T-CELL IMMUNOTHERAPY: CELL SURFACE ANTIGEN AND HLA class I EXPRESSION IN PEDIATRIC BRAIN TUMORS ARE HETEROGENOUS